These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12719897)

  • 1. Therapeutic effect of a single peritumoural dose of IL-2 on transplanted murine breast cancer.
    Moiseeva EV; Merkulova IB; Bijleveld C; Koten JW; Miroshnikov AI; Den Otter W
    Cancer Immunol Immunother; 2003 Aug; 52(8):487-96. PubMed ID: 12719897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of local interleukin-2 treatment on spontaneous tumours of different immunogenic strength.
    Fiszer-Maliszewska L; Den Otter W; Mordarski M
    Cancer Immunol Immunother; 1999 Feb; 47(6):307-14. PubMed ID: 10203060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local interleukin 2 therapy is most effective against cancer when injected intratumourally.
    Jacobs JJ; Sparendam D; Den Otter W
    Cancer Immunol Immunother; 2005 Jul; 54(7):647-54. PubMed ID: 15685449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of repeated cycles of local IL-2 injections in mice carrying slowly growing tumour grafts.
    Símová J; Bubeník J; Indrová M; Bubeníková D; Jandlová T
    Folia Biol (Praha); 1993; 39(6):315-22. PubMed ID: 7926162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models.
    Guo S; Smeltz RB; Nanajian A; Heller R
    Front Immunol; 2020; 11():614667. PubMed ID: 33628206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chemically induced autochthonous rat mammary and colorectal carcinomas with interleukin-2.
    Berger MR; Salas M; Garzon F; Petru E; Schwulera U; Schmähl D
    Cancer Immunol Immunother; 1991; 33(5):346-9. PubMed ID: 1868493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local therapy of cancer with free IL-2.
    Den Otter W; Jacobs JJ; Battermann JJ; Hordijk GJ; Krastev Z; Moiseeva EV; Stewart RJ; Ziekman PG; Koten JW
    Cancer Immunol Immunother; 2008 Jul; 57(7):931-50. PubMed ID: 18256831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2.
    Jackaman C; Bundell CS; Kinnear BF; Smith AM; Filion P; van Hagen D; Robinson BW; Nelson DJ
    J Immunol; 2003 Nov; 171(10):5051-63. PubMed ID: 14607902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer.
    Kundu N; Beaty TL; Jackson MJ; Fulton AM
    J Natl Cancer Inst; 1996 Apr; 88(8):536-41. PubMed ID: 8606382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice.
    Orucevic A; Lala PK
    Br J Cancer; 1996 Jan; 73(2):189-96. PubMed ID: 8546905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of colon tumor cells expressing FLT-3 ligand plus systemic IL-2 in mice with syngeneic colon cancer.
    Sivanandham M; Stavropoulos CI; Kim EM; Mancke B; Wallack MK
    Cancer Immunol Immunother; 2002 Apr; 51(2):63-71. PubMed ID: 11904730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma.
    Wigginton JM; Komschlies KL; Back TC; Franco JL; Brunda MJ; Wiltrout RH
    J Natl Cancer Inst; 1996 Jan; 88(1):38-43. PubMed ID: 8847724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast carcinoma.
    Ewend MG; Sampath P; Williams JA; Tyler BM; Brem H
    Neurosurgery; 1998 Nov; 43(5):1185-93. PubMed ID: 9802862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of biological response modifiers against transplantable mouse tumors of spontaneous origin. II. Local interleukin 2 treatment of tumors of different immunogenic strength.
    Fiszer-Maliszewska L; Den Otter W; Madej JA; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1998; 46(5):293-300. PubMed ID: 9832068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemo-immunotherapy of murine solid tumor with OK-432, G-CSF, IL-2, and chemotherapeutics.
    Iida S; Matsuoka S; Kudo C; Moriya Y; Yoshida T; Saito M
    Int J Immunopharmacol; 1995 Dec; 17(12):973-80. PubMed ID: 8964656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination. effects on tumour growth, capillary leakage and nitric oxide (NO) production.
    Timoshenko AV; Lan Y; Gabius HJ; Lala PK
    Eur J Cancer; 2001 Oct; 37(15):1910-20. PubMed ID: 11576848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local cytokine treatment of HPV16-associated tumours results in inhibition of their lung metastases.
    Mikysková R; Bubenik J; Mendoza L; Vonka V; Smahel M; Símová J; Jandlová T
    Clin Exp Metastasis; 2000; 18(7):581-7. PubMed ID: 11688963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-12 inhibits angiogenesis and growth of transplanted but not in situ mouse mammary tumor virus-induced mammary carcinomas.
    Lee JC; Kim DC; Gee MS; Saunders HM; Sehgal CM; Feldman MD; Ross SR; Lee WM
    Cancer Res; 2002 Feb; 62(3):747-55. PubMed ID: 11830529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells.
    Nakata A; Tsujimura T; Sugihara A; Okamura H; Iwasaki T; Shinkai K; Iwata N; Kakishita E; Akedo H; Terada N
    Anticancer Res; 1999; 19(5B):4131-8. PubMed ID: 10628364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor effects of interleukin-2 and interleukin-1 in mice transplanted with different syngeneic tumors.
    Belardelli F; Ciolli V; Testa U; Montesoro E; Bulgarini D; Proietti E; Borghi P; Sestili P; Locardi C; Peschle C
    Int J Cancer; 1989 Dec; 44(6):1108-16. PubMed ID: 2606579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.